HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recurrent Kikuchi-Fujimoto Disease Successfully Treated by the Concomitant Use of Hydroxychloroquine and Corticosteroids.

Abstract
Kikuchi-Fujimoto disease (KFD) is a benign disease of unknown etiology characterized by lymphadenopathy and a fever. For the majority of patients with KFD, the course is self-limited; however, the optimum method of managing recurrent cases has not yet been established. We herein report a case of a 42-year-old Japanese woman with KFD (confirmed by a lymph node biopsy). Although high-dose prednisolone (PSL) rapidly induced remission, she experienced four recurrences on treatment tapering. Concomitant use of hydroxychloroquine (HCQ) with low-dose PSL induced continuous remission. This is the first case to suggest the effectiveness of HCQ for recurrent KFD in a Japanese patient.
AuthorsFumika Honda, Hiroto Tsuboi, Hirofumi Toko, Ayako Ohyama, Hidenori Takahashi, Saori Abe, Masahiro Yokosawa, Hiromitsu Asashima, Shinya Hagiwara, Tomoya Hirota, Yuya Kondo, Isao Matsumoto, Takayuki Sumida
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 56 Issue 24 Pg. 3373-3377 (Dec 15 2017) ISSN: 1349-7235 [Electronic] Japan
PMID29021444 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunosuppressive Agents
  • Hydroxychloroquine
  • Prednisolone
Topics
  • Adult
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Female
  • Histiocytic Necrotizing Lymphadenitis (drug therapy)
  • Humans
  • Hydroxychloroquine (administration & dosage, therapeutic use)
  • Immunosuppressive Agents (administration & dosage, therapeutic use)
  • Prednisolone (administration & dosage, therapeutic use)
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: